Healthcare professionals must stay updated with the latest research findings. Journal articles, often perceived as the gold standard of medical knowledge, play a pivotal role in shaping clinical practices, policies, and patient care. However, the question arises: Can healthcare professionals unequivocally trust journal articles?

Patents play a crucial role in protecting intellectual property and fostering innovation. However, over the years, the pharmaceutical industry has been criticized for manipulating the patent system to extend its monopoly on drugs, keeping prices high, and limiting access to essential medications. This blog post delves into the tactics employed by Big Pharma to exploit the patent system, the impact on consumers and healthcare, and the potential solutions to address these abuses.

The NIH identified 273 drugs in a review of FDA oncologic drug approvals. After applying exclusion criteria, 224 cancer drug approvals across 119 individual drugs were analyzed. Across all tumor types, the median annual cost for a course of an anticancer drug was $196,000 (IQR, $170,000-$277,000). As ASCO begins in Chicago, there will be a lot of PR targeted at Wall Street analysts but minimal discussion about the cost of cancer drugs.

Pharma companies have increasingly turned to websites as crucial tools for disseminating information, engaging healthcare professionals (HCPs) and patients, and driving brand loyalty. However, simply having a website is not enough; its effectiveness must be measured to ensure it meets its objectives and provides a meaningful return on investment. Here are key metrics and methods for evaluating the efficacy of pharmaceutical product websites.

The media loves to stir the flames of division with articles on everything from politics to healthcare. However, the truth about healthcare and pharma is often hard to digest for many of us. We would rather blame everyone for our healthcare problems but also need to look inward. Here are some inconvenient truths.

Drug approval by regulatory agencies, notably the U.S. Food and Drug Administration (FDA), is a crucial step in ensuring the safety and efficacy of pharmaceuticals before they reach the market. However, in recent years, there has been growing debate over whether the FDA’s approval process has become excessively stringent, potentially hindering innovation and delaying patient access to life-saving treatments. In this blog post, we’ll delve into the complexities of the FDA’s drug approval process, explore common misconceptions, and examine whether the agency is becoming too demanding in approving new drugs.

In the ever-evolving pharma industry, one strategy has increasingly gained prominence: Direct-to-Consumer (DTC) marketing. While traditional marketing tactics have their place, the rise of DTC marketing presents a unique opportunity for pharmaceutical companies to directly engage with patients, educate them about health conditions, and promote their products. However, convincing senior executives of the importance of DTC marketing can sometimes be challenging. In this blog post, we’ll explore why DTC marketing is essential for success in the pharma industry and how to communicate its value to senior leadership effectively.